Cargando…
Pulmonary vascular disease for the general respiratory clinician
Pulmonary vascular disease is relevant to many practising respiratory clinicians: ∼1% of the world's population is estimated to have PH, and it is an important consequence of many other respiratory diseases (e.g. COPD, ILD, sleep breathing disorders) https://bit.ly/3hLqUx1
Autor principal: | Kent, Brian D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973476/ https://www.ncbi.nlm.nih.gov/pubmed/36867114 http://dx.doi.org/10.1183/20734735.0261-2022 |
Ejemplares similares
-
The changing face of the modern respiratory clinician
por: Kent, Brian D.
Publicado: (2023) -
Infectious disease in respiratory medicine
por: Kent, Brian D.
Publicado: (2022) -
Targeted therapy in respiratory disease
por: Kent, Brian D.
Publicado: (2021) -
Climate change, the environment and respiratory disease
por: Kent, Brian D.
Publicado: (2023) -
Pulmonary Vascular Disease in Premature Infants. Early Predictive Models of Late Respiratory Morbidity
por: Levy, Philip T., et al.
Publicado: (2019)